Palmoplantar pustulosishttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Ko te Palmoplantar pustulosis he pustular dermatosis mau tonu (ara, he pustulosis, he psoriasis pustular) kei runga i nga nikau me nga kapu anake, e tohuhia ana e nga pustules intraepidermal kua whakakiia ki te neutrophils. Ko te whakamahi i nga retinoids punaha anake me te whakakotahi me te photochemotherapy hei whakapai ake i nga tohu o palmoplantar pustulosis.

○ Maimoatanga
He whai hua te acitretin waha mo tenei momo psoriasis.
#Acitretin
☆ I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
  • I tenei keehi, ka taea hoki te whakapae a pompholyx.
  • I te korenga o te pustules, ka taea hoki te kiia te hakihaki ringa hei tātaritanga rereke.
References Palmoplantar Psoriasis 28846363 
NIH
Ko te Palmoplantar psoriasis he momo psoriasis ka pa te nuinga o te kiri ki o ringaringa me o kapu. Ka kitea he kiri matotoru me te maroke, te pupuhi, te huinga ranei o nga momo e rua.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).